{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:52:51Z","timestamp":1792011171553,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis US LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lanmic.2026.101447","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:37:39Z","timestamp":1791920259000},"page":"101447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunogenicity and shedding of live-attenuated intranasal respiratory syncytial virus vaccine in children aged 6\u201318 months by baseline serostatus: a multicentre, randomised, placebo-controlled, phase 1\/2 trial"],"prefix":"10.1016","author":[{"given":"Olubukola T","family":"Idoko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9299-6428","authenticated-orcid":false,"given":"Sergio L","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin","family":"Bueso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henderson","family":"Edward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman","family":"Banooni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1043-1771","authenticated-orcid":false,"given":"Shaun","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6130-5532","authenticated-orcid":false,"given":"Stephane","family":"Janicot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Vercasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Pallardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapi","family":"Nteene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haritha","family":"Adhikarla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Gerchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gasparotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Gallichan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula J","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanie","family":"Sesay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Gurunathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"De Bruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep S","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2026.101447_bib1","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.lanmic.2026.101447_bib2","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.immuni.2024.05.019","article-title":"Longitudinal humoral analysis in RSV-infected infants identifies pre-existing RSV strain-specific G and evolving cross-reactive F antibodies","volume":"57","author":"Nziza","year":"2024","journal-title":"Immunity"},{"issue":"suppl","key":"10.1016\/j.lanmic.2026.101447_bib3","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1067\/S0022-3476(03)00508-0","article-title":"Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection","volume":"143","author":"Welliver","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.lanmic.2026.101447_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12016-013-8368-9","article-title":"Respiratory syncytial virus--a comprehensive review","volume":"45","author":"Borchers","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.lanmic.2026.101447_bib7","first-page":"543","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus","volume":"140","author":"Glezen","year":"1986","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.lanmic.2026.101447_bib8","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(22)00291-2","article-title":"Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape","volume":"23","author":"Mazur","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101447_bib9","first-page":"259","article-title":"Live-attenuated respiratory syncytial virus vaccines","volume":"372","author":"Karron","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.lanmic.2026.101447_bib10","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1016\/j.vaccine.2007.08.014","article-title":"The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines","volume":"25","author":"Wright","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2026.101447_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/infdis\/jiad281","article-title":"Evaluation of the live-attenuated intranasal respiratory syncytial virus (RSV) vaccine RSV\/6120\/\u0394NS2\/1030s in RSV-seronegative young children","volume":"229","author":"Karron","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101447_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/infdis\/jiz408","article-title":"Safety and immunogenicity of the respiratory syncytial virus vaccine RSV\/\u0394NS2\/\u03941313\/I1314L in RSV-seronegative children","volume":"222","author":"Karron","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101447_bib14","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1128\/JVI.02769-12","article-title":"Respiratory syncytial virus modified by deletions of the NS2 gene and amino acid S1313 of the L polymerase protein is a temperature-sensitive, live-attenuated vaccine candidate that is phenotypically stable at physiological temperature","volume":"87","author":"Luongo","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.lanmic.2026.101447_bib15","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2500026","article-title":"Live-attenuated intranasal RSV vaccine in infants and toddlers","volume":"4","author":"Idoko","year":"2025","journal-title":"NEJM Evid"},{"key":"10.1016\/j.lanmic.2026.101447_bib16","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/infdis\/jiac253","article-title":"Evaluation of recombinant live-attenuated respiratory syncytial virus (RSV) vaccines RSV\/\u0394NS2\/\u03941313\/I1314L and RSV\/276 in RSV-seronegative children","volume":"226","author":"Cunningham","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101447_bib17","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1016\/j.vaccine.2021.01.055","article-title":"Vaccine-associated enhanced disease: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"39","author":"Munoz","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2026.101447_bib18","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1128\/JVI.79.13.8651-8654.2005","article-title":"Growth of respiratory syncytial virus in primary epithelial cells from the human respiratory tract","volume":"79","author":"Wright","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.lanmic.2026.101447_bib19","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/infdis\/jit089","article-title":"Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokines","volume":"207","author":"Karron","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101447_bib20","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/infdis\/jiae055","article-title":"Correlates of rotavirus vaccine shedding and seroconversion in a US cohort of healthy infants","volume":"230","author":"Burke","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101447_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11095-020-02976-9","article-title":"Evaluation of intranasal vaccine delivery using anatomical replicas of infant nasal airways","volume":"38","author":"Wilkins","year":"2021","journal-title":"Pharm Res"},{"key":"10.1016\/j.lanmic.2026.101447_bib22","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.3390\/microorganisms12112305","article-title":"Immune responses to respiratory syncytial virus vaccines: advances and challenges","volume":"12","author":"Silva","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.lanmic.2026.101447_bib23","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/infdis\/jiaa049","article-title":"Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with small hydrophobic noncoding region is highly immunogenic in children","volume":"221","author":"McFarland","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101447_bib24","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/infdis\/jiy066","article-title":"Live respiratory syncytial virus (RSV) vaccine candidate containing stabilized temperature-sensitivity mutations is highly attenuated in RSV-seronegative infants and children","volume":"217","author":"Buchholz","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101447_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077104","article-title":"Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age","volume":"8","author":"Malkin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2026.101447_bib26","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1016\/S0264-410X(03)00355-4","article-title":"Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies","volume":"21","author":"Piedra","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2026.101447_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/pai.70257","article-title":"Prophylactic monoclonal antibodies against respiratory syncytial virus in early life: an in-depth review of mechanisms of action, failure factors, and future perspectives","volume":"36","author":"Bizot","year":"2025","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.lanmic.2026.101447_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/21645515.2016.1239668","article-title":"Current prospects and future challenges for nasal vaccine delivery","volume":"13","author":"Yusuf","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.lanmic.2026.101447_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s43556-025-00301-7","article-title":"Mucosal immunity and vaccination strategies: current insights and future perspectives","volume":"6","author":"Zhang","year":"2025","journal-title":"Mol Biomed"},{"key":"10.1016\/j.lanmic.2026.101447_bib30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/427813","article-title":"Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants","volume":"191","author":"Karron","year":"2005","journal-title":"J Infect Dis"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524726001023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524726001023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:34:22Z","timestamp":1792010062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524726001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"alternative-id":["S2666524726001023"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2026.101447","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and shedding of live-attenuated intranasal respiratory syncytial virus vaccine in children aged 6\u201318 months by baseline serostatus: a multicentre, randomised, placebo-controlled, phase 1\/2 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2026.101447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101447"}}